Associated Papers
SEAP-GETNE consensus on prognostic and predictive molecular biomarkers in thyroid cancer.
Ruz-Caracuel I et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia, 2026
Utility of digital PCR for detecting TERT promoter mutations and CDKN2A homozygous deletion in meningioma.
Kodama T et al.
Brain Tumor Pathology, 2026
Malignant struma ovarii: Advances in molecular pathogenesis, classification, diagnosis and treatment.
Lin W et al.
Histopathology, 2026
Highly sensitive profiling somatic mutations of thyroid cancer by nucleotide-enrichment-based MALDI-TOF MS assay.
Bai H et al.
Scientific Reports, 2026
Long-Read Amplicon Sequencing for the Detection of TERT Promoter Variant Clonal Hematopoiesis in Patients with Telomere Biology Disorders.
Kirchner R et al.
The Journal of Molecular Diagnostics : Jmd, 2026
Molecular insight into Proliferative Verrucous Leukoplakia: Are TERT promoter mutations a predictive marker?
Garg N et al.
Virchows Archiv : an International Journal of Pathology, 2026
Detection of TERT Promoter Mutations in Papillary Thyroid Carcinoma Using Droplet Digital PCR and Their Association with Aggressive Tumor Features.
Lee J et al.
International Journal of Molecular Sciences, 2026
Tumor-informed liquid biopsy for monitoring thyroid cancer: a proof-of-concept study.
Thomaz DMD et al.
European Thyroid Journal, 2026
Characterizing thyroid carcinomas in the elderly: Histological subtypes and TERT promoter mutation analysis based on the latest WHO classification.
Koh MJ et al.
Annals of Diagnostic Pathology, 2026
A Granular Cell Variant of Adult Primary Leptomeningeal Gliomatosis Mimicking a Granulomatous Process: A Case Report With Molecular Characterization.
Brito NJV et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology, 2026
Mutational patterns and ancestry-linked profiles in a large hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma cohort.
Gerdes C et al.
Esmo Open, 2026
Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumors.
Brand F et al.
Acta Neuropathologica, 2026
Mucoepidermoid carcinoma of the thyroid gland: genetic insights and a rare clinical presentation.
Dixit S et al.
Virchows Archiv : an International Journal of Pathology, 2026
Preoperative Detection of Dual TERT Promoter Mutations in Thyroid Cancer: A Case Series.
Harari A et al.
Diagnostic Cytopathology, 2026
The Occurrence of Gene Fusions in Thyroid Lesions and the Relation With Chronic Lymphocytic Thyroiditis.
Jentus MM et al.
Pathology International, 2026
Adult male patients with DKC1 mutations present early-onset pulmonary fibrosis and severe prognosis.
Evrard O et al.
Erj Open Research, 2026
Pediatric and Adolescent/Young Adult High-Grade Gliomas With Adult-Type Molecular Features.
Singh J et al.
Pathology International, 2026
INSM1 governs a neuronal progenitor state that drives glioblastoma in a human stem cell model.
DeSouza PA et al.
Nature Communications, 2025
Nationwide comprehensive genomic profiling defines the genomic landscape of hepatocellular carcinoma across etiologies.
Yasugi K et al.
Scientific Reports, 2025
Rapid intraoperative genetic analysis of adult-type diffuse gliomas using a microfluidic real-time polymerase chain reaction device.
Maeda S et al.
Neuro-oncology, 2025
Advances in the management of patients with IDH-mutant glioma.
Rossi J et al.
The Oncologist, 2025
Prognostic role of the BRAF V600E variant in the preoperative biopsy in differentiated thyroid cancer.
Carrillo JF et al.
Journal of Endocrinological Investigation, 2025
Ovarian Sex Cord Tumor With Annular Tubules (SCTAT) Harbor Recurrent Copy Number Alterations, Including Monosomy 22.
Leader AM et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2025
Retroelements in thyroid cancer: epigenetic plasticity, dedifferentiation, and therapeutic opportunities.
D'Alessandre NDR et al.
Reviews in Endocrine & Metabolic Disorders, 2025
Circulating chromatin reveals the effects of disease-associated variants on gene regulation.
Zhang Z et al.
Biorxiv : the Preprint Server for Biology, 2025
Exploring the Molecular Features and Clinicopathological Correlations of Diffuse Sclerosing Papillary Thyroid Carcinoma.
Zhang Y et al.
Clinical Endocrinology, 2025
Genetic investigation in patients with histological variants of bladder cancer: clinical implications.
Emtiazi N et al.
Expert Review of Anticancer Therapy, 2025
Clinicopathologic, immunohistochemical and genomic characterization of urothelial carcinoma with myxoid and chordoid features.
Zhao T et al.
Histopathology, 2025
A subgroup of anaplastic thyroid carcinomas harbors MET alterations with potential therapeutic options.
Theurer S et al.
Pathology, Research and Practice, 2025
Molecular Characterization and Phenotype-Genotype Correlation of Childhood Thyroid Nodules and Cancers: A Study of 62 Patients.
Aycan Z et al.
Hormone Research in Paediatrics, 2025
Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients.
Yanagida S et al.
Journal of Gynecologic Oncology, 2025
Molecular and immune characteristics of neuroendocrine bladder carcinoma - Implications for diagnosis, prognosis, and therapy: A review.
Zhang T et al.
Biomolecules & Biomedicine, 2025
Diagnosis and management of adult telomere biology disorders.
Franke M et al.
Haematologica, 2025
Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients?
Nozzoli F et al.
Neuro-oncology, 2025
Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells.
Calafato G et al.
European Thyroid Journal, 2025
Genomic profiling of urological malignancies using tissue-based next generation sequencing.
Alruwaii ZI et al.
Urologic Oncology, 2025
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract.
Rammal R et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2025
Investigation of Possible Telomerase Reverse Transcriptase Promoter Mutation in Human Chemically Induced Liver Progenitors.
Askeyev B et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology, 2025
Disease-Specific and Histological Outcomes of Preoperative TERT Promoter Mutation Detected in Isolation or in Combination with Other Mutations in Thyroid Neoplasms.
Calcaterra M et al.
Thyroid : Official Journal of the American Thyroid Association, 2025
TERT promoter mutations in meningiomas: associations with clinicopathological features and insights into spatial and temporal heterogeneity in a 165-case cohort.
Boduroğlu A et al.
Pathology, Research and Practice, 2025
DICER1 mutations in Bethesda III/IV thyroid cytology samples: A multicenter observational study.
Karimkhan A et al.
Cancer Cytopathology, 2025
Genetic Markers and Mutations in Primary Spinal Cord Tumors and Their Impact on Clinical Management.
Motiei-Langroudi R
Brain Sciences, 2025
Prognostic significance of BRAF V600E and TERT promoter mutations in radioiodine resistance and recurrence of differentiated thyroid cancer.
Nhung LTT et al.
Medicine, 2025
Meningioma with trabecular architecture: a harbinger of BAP1 deficiency.
Okuno N et al.
Brain Tumor Pathology, 2025
Progression of Follicular Thyroid Carcinomas to Anaplastic Thyroid Carcinomas: Molecular and Clinicopathologic Characteristics with Comparison to Papillary Thyroid Carcinoma-Derived Anaplastic Thyroid Carcinomas.
Odate T et al.
Endocrine Pathology, 2025
Development and Performance Validation of a Comprehensive Liquid Biopsy Genotyping Panel for Pan-cancer Analysis.
Lim S et al.
Annals of Laboratory Medicine, 2025
Exploring the role of TERT in thyroid Cancer: A systematic review.
Maloberti T et al.
Critical Reviews in Oncology/hematology, 2025
Analysis of TERT association with clinical outcome in meningiomas: a multi-institutional cohort study.
Gui C et al.
The Lancet. Oncology, 2025
Histopathological, Immunohistochemical, Molecular and Genetic Biomarkers in Differentiated Thyroid Cancer.
Al-Abbadi MA et al.
Cancers, 2025
Leveraging sequences missing from the human genome to diagnose cancer.
Georgakopoulos-Soares I et al.
Communications Medicine, 2025